<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>Unitus DSpace</title>
  <link rel="alternate" href="http://http://dspace.unitus.it:80" />
  <subtitle>The DSpace digital repository system captures, stores, indexes, preserves, and distributes digital research material.</subtitle>
  <id>http://http://dspace.unitus.it:80</id>
  <updated>2013-05-24T18:15:38Z</updated>
  <dc:date>2013-05-24T18:15:38Z</dc:date>
  <entry>
    <title>The use of filamentous bacteriophage fd to deliver MAGE-A10 or MAGE-A3 HLA-A2-restricted peptides and to induce strong antitumor CTL responses</title>
    <link rel="alternate" href="http://hdl.handle.net/2067/1577" />
    <author>
      <name>Sartorius, Rossella</name>
    </author>
    <author>
      <name>Pisu, Paola</name>
    </author>
    <author>
      <name>D'Apice, Luciana</name>
    </author>
    <author>
      <name>Pizzella, Luciano</name>
    </author>
    <author>
      <name>Romano, Chiara</name>
    </author>
    <author>
      <name>Cortese, Giancarlo</name>
    </author>
    <author>
      <name>Giorgini, Angela</name>
    </author>
    <author>
      <name>Santoni, Angela</name>
    </author>
    <author>
      <name>De Berardinis, Piergiuseppe</name>
    </author>
    <author>
      <name>Velotti, Francesca</name>
    </author>
    <id>http://hdl.handle.net/2067/1577</id>
    <updated>2011-09-26T23:05:34Z</updated>
    <published>2007-12-31T23:00:00Z</published>
    <summary type="text">Title: The use of filamentous bacteriophage fd to deliver MAGE-A10 or MAGE-A3 HLA-A2-restricted peptides and to induce strong antitumor CTL responses
Authors: Sartorius, Rossella; Pisu, Paola; D'Apice, Luciana; Pizzella, Luciano; Romano, Chiara; Cortese, Giancarlo; Giorgini, Angela; Santoni, Angela; De Berardinis, Piergiuseppe; Velotti, Francesca
Abstract: Delivery of tumor-associated antigen (TAA)-derived peptides in a high immunogenic form represents one of the key issues for effective peptide-based cancer vaccine development. Here, we report the ability of non-pathogenic filamentous bacteriophage fd virions to deliver HLA-A2-restricted MAGE-A10254-262- or MAGE-A3271-279-derived peptides and elicit potent specific CTL responses in vitro and in vivo. Interestingly, human anti-MAGE-A3271-279-specific CTLs were able to kill human MAGE-A3+ tumor cells, even if these cells naturally express a low amount of MAGE-A3271-279 peptide-HLA epitope surface complexes and are usually not recognized by CTLs generated by conventional stimulation procedures. MAGE-A3271-279-specific/CD8+ CTL clones were isolated from in vitro cultures and their high avidity for antigen recognition was assessed. Moreover, in vivo tumor protection assay showed that vaccination of humanized HHD (HLA-A2.1+/H2-Db+) transgenic mice with phage particles expressing MAGE-A3271-279-derived peptides hampered tumor growth. Overall, these data indicate that engineered filamentous bacteriophage virions increase substantially the immunogenicity of delivered TAA-derived peptides, thus representing a novel powerful system for the development of effective peptide-based cancer vaccines.
Description: L'articolo è disponibile sul sito dell'editore http://www.jimmunol.org</summary>
    <dc:date>2007-12-31T23:00:00Z</dc:date>
  </entry>
</feed>

